Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Depression symptoms and treatment among HIV infected and uninfected veterans.

Sueoka K, Goulet JL, Fiellin DA, Rimland D, Butt AA, Gibert C, Rodriguez-Barradas MC, Bryant K, Crystal S, Justice AC.

AIDS Behav. 2010 Apr;14(2):272-9. doi: 10.1007/s10461-008-9428-7. Epub 2008 Jul 22.

2.

Time to depression treatment in primary care among HIV-infected and uninfected veterans.

Hooshyar D, Goulet J, Chwastiak L, Crystal S, Gibert C, Mattocks K, Rimland D, Rodriguez-Barradas M, Justice AC; VACS Project Team..

J Gen Intern Med. 2010 Jul;25(7):656-62. doi: 10.1007/s11606-010-1323-z. Epub 2010 Apr 20.

3.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
4.

Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection.

Sullivan LE, Goulet JL, Justice AC, Fiellin DA.

Drug Alcohol Depend. 2011 Sep 1;117(2-3):158-63. doi: 10.1016/j.drugalcdep.2011.01.014. Epub 2011 Feb 22.

5.

Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions.

Papakostas GI, Kornstein SG, Clayton AH, Soares CN, Hallett LA, Krishen A, Tucker VL.

Int Clin Psychopharmacol. 2007 Jul;22(4):226-9.

PMID:
17519646
6.

Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality.

Ried LD, Jia H, Feng H, Cameon R, Wang X, Tueth M, Wu SS.

Ann Pharmacother. 2011 Jul;45(7-8):888-97. doi: 10.1345/aph.1P478. Epub 2011 Jul 12.

PMID:
21750310
7.

Depression in primary care: interpersonal counseling vs selective serotonin reuptake inhibitors. The DEPICS Study. A multicenter randomized controlled trial. Rationale and design.

Menchetti M, Bortolotti B, Rucci P, Scocco P, Bombi A, Berardi D; DEPICS Study Group..

BMC Psychiatry. 2010 Nov 25;10:97. doi: 10.1186/1471-244X-10-97.

8.

Antidepressants for people with epilepsy and depression.

Maguire MJ, Weston J, Singh J, Marson AG.

Cochrane Database Syst Rev. 2014 Dec 3;(12):CD010682. doi: 10.1002/14651858.CD010682.pub2. Review.

PMID:
25464360
9.

Veterans aging cohort three-site study (VACS 3): overview and description.

Smola S, Justice AC, Wagner J, Rabeneck L, Weissman S, Rodriguez-Barradas M; VACS 3 Project Team..

J Clin Epidemiol. 2001 Dec;54 Suppl 1:S61-76.

PMID:
11750212
10.

The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.

Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.

Eur Arch Psychiatry Clin Neurosci. 2009 Apr;259(3):172-85. doi: 10.1007/s00406-008-0849-0. Epub 2009 Jan 22.

PMID:
19165525
11.

Does prestroke depression impact poststroke depression and treatment?

Ried LD, Jia H, Cameon R, Feng H, Wang X, Tueth M.

Am J Geriatr Psychiatry. 2010 Jul;18(7):624-33. doi: 10.1097/JGP.0b013e3181ca822b.

PMID:
20220578
12.

Serotonin reuptake inhibitor use, depression, and long-term outcomes after an acute coronary syndrome: a prospective cohort study.

Rieckmann N, Kronish IM, Shapiro PA, Whang W, Davidson KW.

JAMA Intern Med. 2013 Jun 24;173(12):1150-1. doi: 10.1001/jamainternmed.2013.910. No abstract available.

13.

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

Kennedy SH, Andersen HF, Lam RW.

J Psychiatry Neurosci. 2006 Mar;31(2):122-31. Erratum in: J Psychiatry Neurosci. 2006 Jul;31(4):228.

14.

Clinical importance of HIV and depressive symptoms among veterans with HIV infection.

Kilbourne AM, Justice AC, Rollman BL, McGinnis KA, Rabeneck L, Weissman S, Smola S, Schultz R, Whittle J, Rodriguez-Barradas M.

J Gen Intern Med. 2002 Jul;17(7):512-20.

15.

Pediatrician and family physician prescription of selective serotonin reuptake inhibitors.

Rushton JL, Clark SJ, Freed GL.

Pediatrics. 2000 Jun;105(6):E82.

PMID:
10835095
16.

Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.

Kendrick T, Chatwin J, Dowrick C, Tylee A, Morriss R, Peveler R, Leese M, McCrone P, Harris T, Moore M, Byng R, Brown G, Barthel S, Mander H, Ring A, Kelly V, Wallace V, Gabbay M, Craig T, Mann A.

Health Technol Assess. 2009 Apr;13(22):iii-iv, ix-xi, 1-159. doi: 10.3310/hta13220.

17.

Nonmedical use of prescription opioids and pain in veterans with and without HIV.

Barry DT, Goulet JL, Kerns RK, Becker WC, Gordon AJ, Justice AC, Fiellin DA.

Pain. 2011 May;152(5):1133-8. doi: 10.1016/j.pain.2011.01.038. Epub 2011 Feb 26.

18.

Paroxetine, a selective serotonin reuptake inhibitor, reduces depressive symptoms and subjective handicaps in patients with dizziness.

Horii A, Mitani K, Kitahara T, Uno A, Takeda N, Kubo T.

Otol Neurotol. 2004 Jul;25(4):536-43.

PMID:
15241233
20.

Supplemental Content

Support Center